Skip to main content

Advertisement

Log in

Intravitreal air bubbles following intravitreal injections: a comprehensive analysis

  • Retinal Disorders
  • Published:
Graefe's Archive for Clinical and Experimental Ophthalmology Aims and scope Submit manuscript

Abstract

Purpose

To evaluate the prevalence of residual air bubbles following intravitreal injections of anti-VEGF agents, and to compare two techniques designed to reduce their occurrence.

Methods

Patients who received intravitreal injections reported the presence of air bubbles following the procedure, and were followed to determine when they disappeared. Two techniques used to reduce air bubbles prior to injection were compared—tapping the syringe with the needle up (“upwards” technique) or down (“downwards” technique). Rates of residual air bubbles were compared between techniques, and between different drugs.

Results

The study included 344 intravitreal injections, 172 injected with each technique. The overall rate of residual air bubbles was 11.3%, with 94.9% resolution by 48 h. The rate was significantly lower with the “downwards” technique (7.5% vs. 15.1%, p = 0.027). It was also significantly lower with ranibizumab injected using pre-filled syringes than with bevacizumab and aflibercept (0% vs. 12.1% and 14.7%, p < 0.0001). A questionnaire revealed patients reported medium levels of discomfort and a high importance of avoiding air bubbles.

Conclusions

Residual air bubbles are a common occurrence, likely to be experienced by most patients undergoing repeated injections. This phenomenon may be significantly reduced by using the described “downwards” technique, or pre-filled syringes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

Data availability

Data is available upon request. No code was used.

References

  1. Pearce W, Hsu J, Yeh S (2015) Advances in drug delivery to the posterior segment. Curr Opin Ophthalmol 26:233–239

    Article  Google Scholar 

  2. Campbell RJ, Bronskill SE, Bell CM, Paterson JM, Whitehead M, Gill SS (2010) Rapid expansion of intravitreal drug injection procedures, 2000 to 2008: a population-based analysis. Arch Ophthalmol 128:359–362

    Article  Google Scholar 

  3. Lai TY, Liu S, Das S, Lam DS (2015) Intravitreal injection–technique and safety. Asia Pac J Ophthalmol (Phila) 4:321–328

    Article  CAS  Google Scholar 

  4. Prenner JL (2011) Anesthesia for intravitreal injection. Retina 31:433–434

    Article  Google Scholar 

  5. Blaha GR, Tilton EP, Barouch FC, Marx JL (2011) Randomized trial of anesthetic methods for intravitreal injections. Retina 31:535–539

    Article  CAS  Google Scholar 

  6. Rodrigues EB, Grumann A Jr, Penha FM, Shiroma H, Rossi E, Meyer CH, Stefano V, Maia M, Magalhaes O Jr, Farah ME (2011) Effect of needle type and injection technique on pain level and vitreal reflux in intravitreal injection. J Ocul Pharmacol Ther 27:197–203

    Article  CAS  Google Scholar 

  7. Moisseiev E, Regenbogen M, Bartfeld Y, Barak A (2012) Evaluation of pain in intravitreal bevacizumab injections. Curr Eye Res 37:813–817

    Article  CAS  Google Scholar 

  8. Doshi RR, Leng T, Fung AE (2012) Reducing oral flora contamination of intravitreal injections with face mask or silence. Retina 32:473–476

    PubMed  Google Scholar 

  9. Schimel AM, Scott IU, Flynn HW Jr (2011) Endophthalmitis after intravitreal injections: should the use of face masks be the standard of care? Arch Ophthalmol 129:1607–1609

    Article  Google Scholar 

  10. Gomi F, Ohashi Y, Ohji M, Intravitreal Injection Study Group (2014) Benefit of ocular draping on bacterial contamination after intravitreal injection using a plate-type eyelid speculum. Nippon Ganka Gakkai Zasshi 118:640–4

    PubMed  Google Scholar 

  11. Hunyor AP, Merani R, Darbar A, Korobelnik JF, Lanzetta P, Okada AA (2018) Topical antibiotics and intravitreal injections. Acta Ophthalmol 96(5):435–441

    Article  Google Scholar 

  12. Avery RL, Bakri SJ, Blumenkranz MS, Brucker AJ, Cunningham ET Jr, D’Amico DJ, Dugel PU, Flynn HW Jr, Freund KB, Haller JA, Jumper JM, Liebmann JM, McCannel CA, Mieler WF, Ta CN, Williams GA (2014) Intravitreal injection technique and monitoring: updated guidelines of an expert panel. Retina 34(Suppl 12):S1–S18

    Article  CAS  Google Scholar 

  13. Moisseiev E, Rudell J, Tieu EV, Yiu G (2017) Effect of syringe design on the accuracy and precision of intravitreal injections of anti-VEGF agents. Curr Eye Res 42(7):1059–1063

    Article  CAS  Google Scholar 

  14. Loewenstein I, Goldstein M, Moisseiev J, Moisseiev E (2019) Accuracy and precision of intravitreal injections of anti-vascular endothelial growth factor agents in real life: what is actually in the syringe? Retina 39(7):1385–1391

    Article  CAS  Google Scholar 

  15. Gualino V, Fourmaux E, Grenet T, Zerbib J, Wolff B (2020) Patient experience of anti-vegf intravitreal injection. J Fr Ophtalmol 43(10):1047–1053

    Article  CAS  Google Scholar 

  16. Martel A, Nahon-Esteve S, Martini K, Almairac F, Baillif S (2020) Feelings, preoperative anxiety, and need for information in patients undergoing intravitreal injections. Graefes Arch Clin Exp Ophthalmol 258(7):1395–1403

    Article  CAS  Google Scholar 

  17. Somner JE, Mansfield D (2009) Inadvertent injection of intravitreal air during intravitreal Lucentis injection for wet age-related macular degeneration: an undescribed complication. Eye (Lond) 23(8):1744

    Article  CAS  Google Scholar 

  18. Sukgen EA, Gunay M, Kocluk Y (2017) Occurrence of intraocular air bubbles during intravitreal injections for retinopathy of prematurity. Int Ophthalmol 37(1):215–219

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

Research design: EM, MK.

Data acquisition: ET, MK.

Data analysis: EM.

Manuscript preparation: EM, ET, MK.

Corresponding author

Correspondence to Elad Moisseiev.

Ethics declarations

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the Meir Medical Center and Clalit Healthcare Organization and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent

This study was approved by the Institutional Review Board of the Tel Aviv Medical Center, and all participants signed informed consent forms.

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Movie 1: A demonstration of the “upwards” technique, using a 1-ml syringe filled with water dyed with fluorescein for visibility. (MOV 3940 KB)

Movie 2: A demonstration of the “downwards” technique, using a 1-ml syringe filled with water dyed with fluorescein for visibility. Following the same steps as in the “upwards” technique, the syringe is then turned downwards, note that the tapping causes some air bubbles to rise toward the plunger. (MOV 4874 KB)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Krauthammer, M., Trabelsi, E. & Moisseiev, E. Intravitreal air bubbles following intravitreal injections: a comprehensive analysis. Graefes Arch Clin Exp Ophthalmol 259, 3697–3702 (2021). https://doi.org/10.1007/s00417-021-05302-0

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00417-021-05302-0

Keywords

Navigation